Intellia Therapeutics Inc diskutieren
Intellia Therapeutics Inc
WKN: A2AG6H / Symbol: NTLA / Name: Intellia / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
12,32 €
-6,84 %
Intellia Therapeutics (NTLA) was upgraded by William Blair from "market perform" to "outperform".
Ratings data for NTLA provided by MarketBeat
Intellia Therapeutics (NTLA) had its price target raised by HC Wainwright from $25.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Intellia Therapeutics (NTLA) had its price target raised by Leerink Partners from $27.00 to $29.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Intellia Therapeutics (NTLA) had its "buy" rating reaffirmed by Brookline Capital Acquisition Corp..
Ratings data for NTLA provided by MarketBeat


Neueste Beiträge
Lake_Street_Capital in Sturm Ruger Co. Inc. diskutieren